Columbia Partners Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-14,781
Closed -$1.56M 245
2018
Q1
$1.56M Buy
14,781
+6,592
+80% +$766K 0.2% 141
2017
Q4
$959K Sell
8,189
-5,450
-40% -$616K 0.13% 170
2017
Q3
$1.55M Buy
13,639
+904
+7% +$104K 0.2% 145
2017
Q2
$1.59M Buy
12,735
+464
+4% +$55K 0.2% 144
2017
Q1
$1.45M Buy
12,271
+3,792
+45% +$430K 0.19% 149
2016
Q4
$849K Sell
8,479
-1,590
-16% -$170K 0.08% 247
2016
Q3
$1.27M Buy
10,069
+150
+2% +$18.5K 0.1% 227
2016
Q2
$1.16M Buy
9,919
+253
+3% +$28.6K 0.09% 255
2016
Q1
$1M Buy
9,666
+588
+6% +$56.9K 0.07% 271
2015
Q4
$904K Sell
9,078
-151
-2% -$14.8K 0.06% 272
2015
Q3
$841K Sell
9,229
-107
-1% -$10.7K 0.06% 291
2015
Q2
$990K Sell
9,336
-174
-2% -$19.3K 0.06% 231
2015
Q1
$1.08M Sell
9,510
-582
-6% -$66.4K 0.06% 227
2014
Q4
$1.11M Sell
10,092
-350
-3% -$36.9K 0.06% 246
2014
Q3
$1.02M Sell
10,442
-4,205
-29% -$414K 0.05% 267
2014
Q2
$1.48M Sell
14,647
-11,843
-45% -$1.16M 0.07% 230
2014
Q1
$2.43M Buy
26,490
+7,285
+38% +$671K 0.11% 204
2013
Q4
$1.74M Sell
19,205
-4,819
-20% -$417K 0.07% 209
2013
Q3
$1.92M Sell
24,024
-4,083
-15% -$321K 0.09% 214
2013
Q2
$2.04M Buy
+28,107
New +$2.1M 0.1% 216

Other funds holding ZBH

Columbia Partners Investment Management's ZBH Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 14,781 shares — an estimated $1.56M sold.

Columbia Partners Investment Management first reported a position in ZBH in Q2 2013 and held it in 20 quarters. The position peaked at $2.43M in Q1 2014. 870 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 14,781 Zimmer Biomet shares in Q2 2018, an estimated $1.56M.
  • Columbia Partners Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 20 quarters.
  • Columbia Partners Investment Management's Zimmer Biomet position peaked at $2.43M in Q1 2014.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.